Shopping Cart
- Remove All
Your shopping cart is currently empty
Rivastigmine tartrate (SDZ-ENA 713) is a carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $47 | In Stock | |
| 50 mg | $55 | In Stock | |
| 100 mg | $81 | In Stock | |
| 200 mg | $108 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $58 | In Stock |
| Description | Rivastigmine tartrate (SDZ-ENA 713) is a carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE. |
| Targets&IC50 | AChR:5.5 μM |
| Synonyms | SDZ-ENA 713, ENA 713 |
| Molecular Weight | 400.43 |
| Formula | C14H22N2O2·C4H6O6 |
| Cas No. | 129101-54-8 |
| Smiles | O[C@H]([C@@H](O)C(O)=O)C(O)=O.CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | Ethanol: 74 mg/mL (184.8 mM), Sonication is recommended. DMSO: 39 mg/mL (97.4 mM), Sonication is recommended. H2O: 73 mg/mL (182.3 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
DMSO/H2O/Ethanol
H2O/Ethanol
| |||||||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.